The first version of this Pulse Report was published in early April 2020.  As the COVID-19 pandemic continues to take its toll on research programs across academia and pharma/biotech globally we are providing this updated complimentary report from Percepta has been provided to help you stay informed on the pandemic’s current impact on laboratory closures, funding, headcount, project changes,…

As the COVID-19 pandemic takes its toll on research programs
across academia and pharma/biotech we are in turn interested to better
understand the current research landscape and how we can best support it.

On April 3, 2020 we fielded a brief survey to the Percepta panel of life scientists. We received 1,015 completed surveys from around the globe.  Key findings from the…

Qiagen’s dominant position remains with leadership in fifteen of the eighteen nucleic acid purification segments surveyed

Carlsbad, Calif. – March
1, 2020 – Today Percepta
Associates released its 2020
DNA Purification, Series 1, Life Science Dashboard™ and 2020
RNA Purification, Series 1, Life Science Dashboard™ reports. These reports
update findings from Percepta’s previously published 2016 Nucleic Acid
Purification Dashboard.  2020 reports see
the addition of several new…

Carlsbad, Calif. – November 9, 2016 – Today Percepta Associates released its 2016 Quantitative Immunoassay, Series 3 Life Science Dashboard™ report which draws comparisons to key market indicator data reported in Percepta’s 2013 Series 2 Dashboard report.   This updated dashboard reveals increased usage of all immunoassay methods surveyed except for colorimetric ELISA, with the best growth opportunities in chemiluminescent…

October 7th 2016 –  Percepta Associates Inc. has been selected for the 2016 California Excellence Award for client services in market research among all its peers and competitors by the American Economic Institute (AEI).

Percepta Associates Inc. has consistently demonstrated a high regard for upholding business ethics and company values. This recognition by AEI marks a significant achievement as an emerging…

Qiagen’s dominant position has eroded in seven of the fifteen segments surveyed, resulting in other suppliers share gain

Carlsbad, Calif. – On June 30th Percepta Associates released its 2016 Nucleic Acid Purification, Series 5 Life Science Dashboard™ report which draws comparisons to key market indicator data reported in Percepta’s 2013 Series 4 Dashboard report.   This updated dashboard reveals a significant…

Today Percepta Associates released its 2016 Protein Electrophoresis and Western Analysis, Series 3 Life Science Dashboard™ market research report which draws comparisons to key market indicator data reported in Percepta’s 2013 Series 2 Dashboard.   This updated dashboard reveals an increase in growth rates for 6 of the 7 product categories surveyed compared to 2013 findings, with highest anticipated growth…

Percepta Associates Inc., a leading provider of market research for the biotools industry, today announced the opening of new offices in Seattle.  The new office space is in the Madrona Business Plaza located at 1421 34th Ave., Seattle, WA  98122 and will provide a second west coast center of operations.

“Percepta’s new offices in Seattle will allow us to expand capabilities beyond our current…

If there is something new to learn about the immune related brain disorders – this is it.  Scientist at the University of Virginia School of Medicine have determined that the brain is directly connected to the immune system by vessels previously thought not to exist.  read more

Researchers at Howard Hughes Medical Institute and Albert Einstein Medical College have reported the development of a promising herpes vaccine using a novel approach to defeating the prevalent virus. The new vaccine works by inducing antibody-dependent cell-mediated cytotoxicity (ADCC), a well studied immuno-response, that signals the immune system to destroy infected cells. Read the…